SARRP used in ER+ Breast Cancer Treatment Research

August 3, 2021

In the recent study, Radiotherapy Delivered Before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer, researchers compared various forms of treatment including radiotherapy, oral palbociclib, or a combination of both. Researchers found that radiotherapy delivered before CDK4/6 inhibitors mediated superior antineoplastic effects compared with alternative treatment schedules. See more below, and the full study here.

Contact Us

Find out more about how Xstrahl will work tirelessly for you

Explore Related Posts